findmyKOL

Shahriar Iravanian, MD

Basic profile

Emory University

ORCIDNPI
RegionAtlanta, GA · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shahriar Iravanian is a Cardiology physician affiliated with Emory University. OpenAlex indexes 87 publications with 1,059 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,059citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

20 Glenlake Pkwy
Kaiser Permanente Glenlake Medical Center
Atlanta, GA 303283473

Telephone

404-365-0966

Registry record last updated 7 Jan 2022.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    65.8%
    Antiarrhythmic26.3%
    Flecainide Acetate37%Dofetilide29%Amiodarone Hcl27%Mexiletine Hcl7%
    Part D<11 patients
    Beta blocker23.7%
    Metoprolol Succinate40%Nadolol19%Sotalol18%Carvedilol14%Metoprolol Tartrate8%
    Part D<11 patients

    + 6 more classes in this area

  • Blood & clotting

    28.6%
    Direct thrombin inhibitors18.1%
    Pradaxa100%
    Part D56 patients
    Factor Xa inhibitor8.4%
    Xarelto57%Eliquis43%
    Part D12 patients

    + 1 more class in this area

  • Anti-infectives

    4.3%
    First-generation cephalosporins4.3%
    Cephalexin100%
    Part D32 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”